Work

Real-world avacopan use in ANCA-associated vasculitis: glucocorticoid exposure and healthcare resource utilization from US claims data

Year: 2026
Type: article
Study design: Observational Study
Abstract: OBJECTIVE: Avacopan is an adjunctive therapy for severe active granulomatosis with polyangiitis and microscopic polyangiitis. We evaluated treatment patterns, glucocorticoid exposure and healthcare resource utilization (HCRU) among adults initiating avacopan, including a sub-cohort aged 65+. METHODS: This retrospective claims analysis utilized Medicare Fee-for-Service and MORE2 Registry® databases. Adults initiating avacopan with 12 months of continuous enrolment before and after index (first claim) were included. Among patients persistent (no ≥ 90-day gap) on avacopan, changes in prednisone-equivalent daily dose (PEDD) and HCRU were evaluated over 12 months in the primary cohort and a 65+ sub-cohort. RESULTS: Of 167 patients (median age 55 years), 53 (31.7%) were age ≥ 65 years. Among patients persistent on avacopan (n = 94), mean PEDD decreased from 12.6 mg/day during the 90 days pre-index to 5.1 mg/day at 12 months post-index in the primary cohort (n = 94), and from 15.1 to 6.9 mg/day in the 65+ sub-cohort (n = 25). In the primary cohort, the proportion of patients with emergency department visits decreased from 62.8% to 39.4%, and inpatient admissions from 55.3% to 21.3%. These reductions were also observed in the 65+ sub-cohort, where both emergency department visits and inpatient admissions declined from 60.0% and 68.0%, respectively, at baseline to below reporting thresholds at follow-up. CONCLUSIONS: In this real-world analysis, avacopan use was associated with reduced glucocorticoid exposure and lower HCRU over 12 months among patients who remained on treatment. These trends were also observed in patients aged 65+. Longer-term comparator studies are needed.
Source: Rheumatology
Language: English
Subfield: Rheumatology
Field: Medicine
Open Access status: hybrid
Estimated APC paid: $4,597
Funder: Amgen
OpenAlex ID: W7226546727
FWCI:
Cites:
Cited by:
Related to: 10